Faculty Members Urge US to Consider Cuban Medicine

Drs. David Armstrong and Marvin Slepian recently traveled to Havana to discuss the drug Heberprot-P with its inventors at the Cuban Center for Genetic Engineering and Biotechnology. The medication, which is described as an "epidermal growth factor," fosters rapid wound healing and could save diabetics from amputation.

They hope that normalizing relations with Cuba will allow them to bring the drug to the U.S. for FDA trials and approval.

Read more from University of Arizona Health Sciences, Arizona Public Media and the Huffington Post.